• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受丘脑底核深部脑刺激治疗的晚期帕金森病患者对左旋多巴的长期反应

Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.

作者信息

Wider Christian, Russmann Heike, Villemure Jean-Guy, Robert Bernadette, Bogousslavsky Julien, Burkhard Pierre R, Vingerhoets François J G

机构信息

Department of Neurology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.

出版信息

Arch Neurol. 2006 Jul;63(7):951-5. doi: 10.1001/archneur.63.7.951.

DOI:10.1001/archneur.63.7.951
PMID:16831963
Abstract

BACKGROUND

Long-duration response (LDR) to levodopa is supposed to decrease with Parkinson disease (PD) progression, but direct observation of this response in advanced PD has never been performed.

OBJECTIVE

To study the LDR to levodopa in patients with advanced PD treated with subthalamic deep brain stimulation (DBS).

DESIGN AND SETTING

We studied 30 consecutive patients with PD who underwent subthalamic DBS. One group had no antiparkinsonian treatment since surgery (no-levodopa group), whereas medical treatment had to be reinitiated in the other group (levodopa group).

MAIN OUTCOME MEASURE

Motor subscale score of the Unified Parkinson's Disease Rating Scale.

RESULTS

Compared with preoperative assessment, evaluation 6 months postoperatively with DBS turned off for 3 hours found a worsening of the motor subscale score of the Unified Parkinson's Disease Rating Scale in the no-levodopa group. This worsening being absent in the levodopa group, it probably reflected the loss of the LDR to levodopa in the no-levodopa group. When DBS was turned on, postoperative motor subscale scores of the Unifid Parkinson's Disease Rating Scale in both groups were similar to preoperative scores while receiving medication, suggesting that subthalamic DBS compensated for the short-duration response and LDR to levodopa.

CONCLUSIONS

Our results suggest that the LDR to levodopa remains significant even in advanced PD, and that subthalamic DBS compensates for the short-duration response and LDR to levodopa.

摘要

背景

左旋多巴的长期反应(LDR)被认为会随着帕金森病(PD)的进展而降低,但从未对晚期PD患者的这种反应进行过直接观察。

目的

研究接受丘脑底核深部脑刺激(DBS)治疗的晚期PD患者对左旋多巴的LDR。

设计与地点

我们研究了30例连续接受丘脑底核DBS治疗的PD患者。一组自手术以来未接受抗帕金森治疗(无左旋多巴组),而另一组则必须重新开始药物治疗(左旋多巴组)。

主要观察指标

统一帕金森病评定量表的运动子量表评分。

结果

与术前评估相比,术后6个月在DBS关闭3小时的情况下进行评估发现,无左旋多巴组统一帕金森病评定量表的运动子量表评分恶化。左旋多巴组未出现这种恶化情况,这可能反映了无左旋多巴组对左旋多巴的LDR丧失。当DBS开启时,两组统一帕金森病评定量表术后运动子量表评分在接受药物治疗时与术前评分相似,这表明丘脑底核DBS补偿了对左旋多巴的短期反应和LDR。

结论

我们的结果表明,即使在晚期PD中,对左旋多巴的LDR仍然显著,并且丘脑底核DBS补偿了对左旋多巴的短期反应和LDR。

相似文献

1
Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.接受丘脑底核深部脑刺激治疗的晚期帕金森病患者对左旋多巴的长期反应
Arch Neurol. 2006 Jul;63(7):951-5. doi: 10.1001/archneur.63.7.951.
2
Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.帕金森病长期双侧丘脑底核刺激的左旋多巴反应
Mov Disord. 2007 May 15;22(7):990-7. doi: 10.1002/mds.21482.
3
Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.通过术前和术后磁共振成像融合图像确定电极位置以及丘脑底核深部脑刺激后的手术结果。
Neurosurgery. 2008 Nov;63(5):925-36; discussion 936-7. doi: 10.1227/01.NEU.0000334045.43940.FB.
4
Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.帕金森病丘脑底核刺激的预后因素:短期与长期效果的比较研究
Stereotact Funct Neurosurg. 2009;87(4):241-8. doi: 10.1159/000225977. Epub 2009 Jun 26.
5
Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.对左旋多巴不耐受的帕金森病患者的丘脑底核刺激
Stereotact Funct Neurosurg. 2007;85(4):169-74. doi: 10.1159/000099076. Epub 2007 Jan 26.
6
Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus.丘脑底核双侧深部脑刺激4年期间帕金森病的进展
Mov Disord. 2006 May;21(5):624-31. doi: 10.1002/mds.20776.
7
Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.帕金森病中苍白球与丘脑底核深部脑刺激的比较
Arch Neurol. 2005 Apr;62(4):554-60. doi: 10.1001/archneur.62.4.554.
8
Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.丘脑底核刺激不会导致帕金森病患者先前存在的幻觉恶化。
Stereotact Funct Neurosurg. 2009;87(1):45-9. doi: 10.1159/000195719. Epub 2009 Jan 28.
9
Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.对单侧丘脑底核深部脑刺激治疗高度不对称帕金森病效果的两年随访
Mov Disord. 2009 Feb 15;24(3):329-35. doi: 10.1002/mds.22211.
10
Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.丘脑底核深部脑刺激治疗帕金森病患者的医疗利用情况和健康状况评估
J Neurol. 2002 Jun;249(6):759-66. doi: 10.1007/s00415-002-0711-7.

引用本文的文献

1
Modulatory effect of levodopa on the basal ganglia-cerebellum connectivity in Parkinson's disease.左旋多巴对帕金森病基底神经节 - 小脑连接性的调节作用。
NPJ Parkinsons Dis. 2025 May 6;11(1):115. doi: 10.1038/s41531-025-00954-9.
2
Detailed investigation of the levodopa response rates in distinct motor subscores in Parkinson's disease patients with and without STN-DBS.对接受和未接受丘脑底核深部脑刺激(STN-DBS)的帕金森病患者不同运动子评分中左旋多巴反应率的详细研究。
Neurodegener Dis Manag. 2025 Feb;15(1):37-45. doi: 10.1080/17582024.2025.2460420. Epub 2025 Feb 24.
3
Improvement by Medication Less than Expected in Parkinson's Disease: Blinded Evaluation of Levodopa Response.
帕金森病药物治疗效果低于预期:左旋多巴反应的盲法评估
Parkinsons Dis. 2024 Feb 21;2024:2649578. doi: 10.1155/2024/2649578. eCollection 2024.
4
Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease.定量纹状体多巴胺能去神经支配作为帕金森病运动结局的预测指标
Mov Disord Clin Pract. 2023 Apr 5;10(6):896-902. doi: 10.1002/mdc3.13726. eCollection 2023 Jun.
5
Adaptive changes in striatal projection neurons explain the long duration response and the emergence of dyskinesias in patients with Parkinson's disease.纹状体投射神经元的适应性变化解释了帕金森病患者的长期反应和运动障碍的出现。
J Neural Transm (Vienna). 2022 Jun;129(5-6):497-503. doi: 10.1007/s00702-022-02510-8. Epub 2022 May 10.
6
Optimizing the selection of Parkinson's disease patients for neuromodulation using the levodopa challenge test.使用左旋多巴激发试验优化帕金森病患者神经调节治疗的选择。
J Neurol. 2022 Feb;269(2):846-852. doi: 10.1007/s00415-021-10666-8. Epub 2021 Jun 30.
7
Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa.帕金森病运动症状的自然史和左旋多巴的长期反应。
Brain. 2020 Aug 1;143(8):2490-2501. doi: 10.1093/brain/awaa181.
8
Efficacy of rasagiline and selegiline in Parkinson's disease: a head-to-head 3-year retrospective case-control study.雷沙吉兰与司来吉兰治疗帕金森病的疗效:一项为期3年的头对头回顾性病例对照研究。
J Neurol. 2017 Jun;264(6):1254-1263. doi: 10.1007/s00415-017-8523-y. Epub 2017 May 26.
9
The missing, the short, and the long: Levodopa responses and dopamine actions.缺失、短暂和持久:左旋多巴反应和多巴胺作用。
Ann Neurol. 2017 Jul;82(1):4-19. doi: 10.1002/ana.24961. Epub 2017 Jun 5.
10
Effect of Age and Disease Duration on the Levodopa Response in Patients with Advanced Parkinson's Disease for Deep Brain Stimulation of the Subthalamic Nucleus.年龄和病程对晚期帕金森病患者丘脑底核深部脑刺激中左旋多巴反应的影响
Front Neurol. 2016 Jun 27;7:97. doi: 10.3389/fneur.2016.00097. eCollection 2016.